Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2005
Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele
Francesc Vidal, Consuelo Viladés, Pere Domingo, et al.
Current HIV Research
|
November 26, 2009
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain
Beatriz Mothe, Iñaki Perez, Pere Domingo, et al.
The Journal of Antimicrobial Chemotherapy
|
October 29, 2022
Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens
Joaquin Burgos, Sergio Moreno-Fornés, Juliana Reyes-Urueña, et al.
AIDS (London, England)
|
October 31, 2023
Life expectancy of people with HIV on antiretroviral therapy in Spain
Inma Jarrín, Marta Rava, Jorge Del Romero Raposo, et al.
AIDS Research and Human Retroviruses
|
April 21, 2006
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients
Anna Bonjoch, Roger Paredes, Pere Domingo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 9, 2006
Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects
Consuelo Viladés, Montserrat Broch, Montserrat Plana, et al.
Open Forum Infectious Diseases
|
November 3, 2025
Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment
Claudio Díaz-García, Sergio Serrano-Villar, Alejandro G García-Ruiz de Morales, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2013
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
Lourdes Anta, José L Blanco, Josep M Llibre, et al.
Journal of Medical Virology
|
July 21, 2005
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
Berta Rodes, Federico García, Carolina Gutierrez, et al.
Plos One
|
March 29, 2019
Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression
Clara Restrepo, Mónica Gutierrez-Rivas, Yolanda M Pacheco, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2005
Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele
Francesc Vidal, Consuelo Viladés, Pere Domingo, et al.
Current HIV Research
|
November 26, 2009
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain
Beatriz Mothe, Iñaki Perez, Pere Domingo, et al.
The Journal of Antimicrobial Chemotherapy
|
October 29, 2022
Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens
Joaquin Burgos, Sergio Moreno-Fornés, Juliana Reyes-Urueña, et al.
AIDS (London, England)
|
October 31, 2023
Life expectancy of people with HIV on antiretroviral therapy in Spain
Inma Jarrín, Marta Rava, Jorge Del Romero Raposo, et al.
AIDS Research and Human Retroviruses
|
April 21, 2006
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients
Anna Bonjoch, Roger Paredes, Pere Domingo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 9, 2006
Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects
Consuelo Viladés, Montserrat Broch, Montserrat Plana, et al.
Open Forum Infectious Diseases
|
November 3, 2025
Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment
Claudio Díaz-García, Sergio Serrano-Villar, Alejandro G García-Ruiz de Morales, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2013
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
Lourdes Anta, José L Blanco, Josep M Llibre, et al.
Journal of Medical Virology
|
July 21, 2005
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
Berta Rodes, Federico García, Carolina Gutierrez, et al.
Plos One
|
March 29, 2019
Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression
Clara Restrepo, Mónica Gutierrez-Rivas, Yolanda M Pacheco, et al.
Page
of 8